Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Some cancer treatments can cause abnormal fine hair growth.

Addressing hair loss's psychological effects with mental health support is crucial for cancer survivors.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Some breast cancer chemotherapy can cause permanent hair loss.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Patients often experience long-lasting changes to their hair after stem cell transplants.

Alopecia mucinosa on the face can be linked to mycosis fungoides, a type of lymphoma.

Some hair loss from medication may reverse after stopping the drug, but treatment options are limited and ongoing research is needed.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Hodgkin's lymphoma can show up as hair loss.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.